Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study
This is a pilot study to test the hypothesis that biofeedback-mediated stress management (BFSM) training can be used to reduce distress and enhance quality of life in patients with non-small cell lung cancer (NSCLC). Most patients with advanced NSCLC have significant physical symptoms, but even those who do not have physical symptoms have high levels of anxiety and depression.
Checked against the public recordLast updated Jul 10, 2015 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Case Comprehensive Cancer Center
- Interventions being studied
- Behavioral: biofeedback-mediated stress management (BFSM)
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patients with a new diagnosis of advanced (stage IV) non-small cell lung cancer (NSCLC) * ECOG performance status 0-1. * Plan to receive care at the Taussig Cancer Center. Exclusion Criteria: * Non-local patients, who will not have the ability to return for 8 study visits. * Patients who are unable to speak and understand English readily, * Patients with significant cognitive impairment.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer CenterCleveland, Ohio
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 10, 2015. Always confirm current availability with the study team.